Company intelligence / Profile preview

AAT Services

United States

Ownership: Private
Development stage: Other

Overview

AAT Bioquest provides advanced research reagents, detection technologies, and custom CRO services to pharma, biotech, and diagnostics companies, supporting high-throughput screening, bioanalytical assay development, and custom synthesis. Their products accelerate drug discovery, diagnostic research, and cell/molecular biology.

Modalities: Small moleculeFluorescent probeNanoparticleAntibodyEnzymeNucleic acidDiagnostic reagent
Industry: Chemicals & Materials

Partnerships

Supplies to leading pharmaceutical and diagnostic companies

Beyond the preview

Go deeper on AAT Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AAT Services.

Explore the full profile